Zydus Cadila launches breast cancer treatment drug Ujvira

The company has launched Trastuzumab Emtansine, the first antibody drug conjugate (ADC) biosimilar and a highly effective drug for treating both early and advanced HER2 positive breast cancer, under the brand name Ujvira, Zydus Cadila said in a statement.

from Moneycontrol Business News https://ift.tt/3oJH5dF